Carotid Intima-Media Thickness Progression in HIV-Infected Adults Occurs Preferentially at the Carotid Bifurcation and Is Predicted by Inflammation.

"Disclosures P.Y.H. has received honoraria from B.M.S. and is currently receiving a grant from Pfizer and GSK. S.G.D. had received research support from Gilead, and has performed ad hoc consulting for Bristol-Myers Squibb, GlaxoSmithKline, ViiV, Tobira and Merck. The other authors have no disclosures."

"Sources of Funding The work was supported by grants from the Doris Duke Charitable Foundation (Clinical Scientist Development Award to PYH), the National Institutes of Health (K23 AI066885, K24AI069994, R01 HL095130, R01 AI052745, R01 CA119903, P30 AI27763, RO1 AI087145, and MO1 RR000083), the UCSF CFAR (PO AI27763), the UCSF CTSI (UL1 RR024131), amfAR (106710-40-RGRL), and the Ragon Institute.The work was presented in part at the 17th Conference on Retroviruses and Opportunistic Infections, February 16–19, 2010, San Francisco, CA."

"Clinical Trial Registration URL: http://clinicaltrials.gov. Unique identifier: NCT01519141"